Cigna Group (CI) stock
CINYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3021% below fair value
$301.45−1.68 (-0.55%)
Close on Nov 11, 2026Market cap $79.66BP/E 13.3Yield 2.00%
Cigna total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cigna's total debt was $31.14B at Sep 30, 2026. For fiscal 2025 it was $31.46B, down 1.6% from the year before. The highest annual figure on record is $42.48B in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.46B | -1.6% |
| FY2024 | Dec 31, 2024 | $31.97B | +3.4% |
| FY2023 | Dec 31, 2023 | $30.93B | -0.5% |
| FY2022 | Dec 31, 2022 | $31.09B | -7.7% |
| FY2021 | Dec 31, 2021 | $33.67B | +2.3% |
| FY2020 | Dec 31, 2020 | $32.92B | -12.0% |
| FY2019 | Dec 31, 2019 | $37.41B | -11.9% |
| FY2018 | Dec 31, 2018 | $42.48B | +681.0% |
| FY2017 | Dec 31, 2017 | $5.44B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $31.14B | -8.5% |
| Q2 FY2026 | Jun 30, 2026 | $31.88B | +3.6% |
| Q1 FY2026 | Mar 31, 2026 | $30.90B | +1.5% |
| Q4 FY2025 | Dec 31, 2025 | $31.46B | -1.6% |
| Q3 FY2025 | Sep 30, 2025 | $34.04B | +3.8% |
| Q2 FY2025 | Jun 30, 2025 | $30.77B | -3.5% |
| Q1 FY2025 | Mar 31, 2025 | $30.45B | -7.1% |
| Q4 FY2024 | Dec 31, 2024 | $31.97B | +3.4% |
| Q3 FY2024 | Sep 30, 2024 | $32.80B | +5.3% |
| Q2 FY2024 | Jun 30, 2024 | $31.89B | -2.6% |
| Q1 FY2024 | Mar 31, 2024 | $32.77B | +0.7% |
| Q4 FY2023 | Dec 31, 2023 | $30.93B | -0.5% |
| Q3 FY2023 | Sep 30, 2023 | $31.14B | -1.4% |
| Q2 FY2023 | Jun 30, 2023 | $32.73B | -1.9% |
| Q1 FY2023 | Mar 31, 2023 | $32.54B | -1.9% |
| Q4 FY2022 | Dec 31, 2022 | $31.09B | -7.7% |
| Q3 FY2022 | Sep 30, 2022 | $31.58B | -8.0% |
| Q2 FY2022 | Jun 30, 2022 | $33.38B | +0.7% |
| Q1 FY2022 | Mar 31, 2022 | $33.19B | +3.8% |
| Q4 FY2021 | Dec 31, 2021 | $33.67B | +2.3% |
| Q3 FY2021 | Sep 30, 2021 | $34.31B | -4.7% |
| Q2 FY2021 | Jun 30, 2021 | $33.14B | -9.3% |
| Q1 FY2021 | Mar 31, 2021 | $31.97B | -12.4% |
| Q4 FY2020 | Dec 31, 2020 | $32.92B | -12.0% |
| Q3 FY2020 | Sep 30, 2020 | $35.99B | -7.1% |
| Q2 FY2020 | Jun 30, 2020 | $36.52B | -6.8% |
| Q1 FY2020 | Mar 31, 2020 | $36.49B | -9.9% |
| Q4 FY2019 | Dec 31, 2019 | $37.41B | -11.9% |
| Q3 FY2019 | Sep 30, 2019 | $38.75B | +612.5% |
| Q2 FY2019 | Jun 30, 2019 | $39.20B | – |
| Q1 FY2019 | Mar 31, 2019 | $40.49B | – |
| Q4 FY2018 | Dec 31, 2018 | $42.48B | – |
| Q4 FY2017 | Dec 31, 2017 | $5.44B | – |
See a number that looks wrong?